Clinical Trial Update: Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study repurposing nucleoside reverse transcriptase inhibitors to treat Alzheimer disease, including early-onset a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment
• Dementia

Snippet

Sponsor: Butler Hospital | Conditions: Alzheimer Disease, Early Onset, Mild Cognitive Impairment | Phase 1 | Status: RECRUITING